光合成におけるエネルギー生産について

Size: px
Start display at page:

Download "光合成におけるエネルギー生産について"

Transcription

1

2 CO 2

3 CO 2

4 RuBisCO

5 phytochromobilin Pr Pfr

6 CO 2

7

8 1 CO2

9 a b

10 b CHO a a -

11 H+ H+ e - e - Mn Yz e - Q B P680 Q A Mn Yz P680 Q A Q B e ē - e - Mn Yz P680 Q A Q B Mn e - Yz P680 e - Q A Q B H 2 O Mn Yz e - P680 e - Q A Q B O 2 H + Mn Yz e - P680 e - Q A Q B PSI

12 Chl Chl Light-harvesting chlorophyll, LHC Chl Chl Chl Chl Chl Chl Chl NADPH Chl Chl Chl H + (CH 2 O) n CO 2 Chl Chl Chl Chl Chl a Chl H + b Chl Chl Chl ATP Chl Chl Chl H + γ β δ α β α c β ε α ADP + Pi ATP ATP

13 - 800 mv Q A /Q B PS II mvh 2 O ½O 2 Z Scheme Fe-S b6/f mv NADP NADP NADPH mv PS I

14 CO 2

15 CO 2 /O 2 RuBP GAP SBP F6P R5P R5P S7P Xu5P SBP Ru5P E4P FBP FBP GAP Xu5P DPGA Ru5P RuBP RuBisCO PGA TP DAHP TP CO 2 O 2 PGA glycolate GAP RuBP glyoxylate glycine P-glycolate PCO serine glycerate CO2O2 hydroxypyruvate O 2 ATP, NADPH

16 RuBisCO CO2 O2 CH2OPO3 - C=O HC-OH HC-OH CH2OPO3 - RuBP C-OH C-OH HC-OH * CH2OPO3 - CH2OPO3 - O 2 CO2 HO - HO - CH2OPO3 - CH2OPO3 - C-COO * - HO C-COO * - C=O - HO-C-OH HC-OH CH2OPO3 - CH2OPO3 - C-OO - C=O HC-OH CH2OPO3 - HC-OH CH2OPO3 - CH2OPO3 - HO C-OO - - HO-C-OH HC-OH CH2OPO3 - CH 2OPO3 - HC-OH * COO - + COO - HC-OH CH2OPO3 - PGA CH2OPO3 - COO - + COO - HC-OH CH2OPO3 - PGA

17 Ci Sr = Vcmax/Kcm)/(Vomax/Kom) CO 2 O 2 CO2 C C SS CO2 O2 Ci Ci Sr

18 -1,6- C6-6- C6 C3) C3) C12) C12) Cn

19 RuBisCO GAP R5P R5P S7P Xu5P SBP SBP Ru5P Xu5P Ru5P RuBP F6P E4P FBP FBP GAP CO 2 O 2 DPGA RuBP RuBisCO PGA TP DAHP TP PGA glycolate GAP glyoxylate glycine P-glycolate PCO serine glycerate O 2 hydroxypyruvate

20 CO2 photons

21 CO 2

22 2000 CO2

23 CO 2 /O 2 CO 2 SuperRuBisCO CO 2 (ppm)

24 PNAS (1997) Science (2003) (rbcs) Cross-talk mrna (rbcl) RuBP mrna worse RuBisCO Form I of cyanobacteria, green algae and higher plants Form II k cat :3-8 s -1 site -1 S rel :10-90 BBRC (2003) JMB (2002) JBC (1997) PCR/PCO cycles CO2/O2 RuBP better RuBisCO Form I of Galdieria and some red algae S rel :240 Engineered Form I k cat :16 s -1 site -1 FEBS Lett. (2002) JB (2001) JBC (1999) BBRC (1997)

25 CO 2 O 2RuBisCO O2 T65 K177 E60 N123 R295 CO 2 RuBisCO RuBisCO CO 2 O 2 RuBisCO RuBisCO loop 6 CO 2 O 2 O 2

26 1 CO CO 2

27 CO 2 CO 2 CO 2

28 Late Embryogenesis Abundant (LEA)

29 P680 II ATP 2 H + NADPH NADP H + CF1 α β LHC2 Phe QA QB P680 D2 D1 Mn 33kD 1/2 O2 27kD H2O + 17kD 2 H + PCR/PCO PQ LHC2 PQ PQ 2 H + Cyt.b6 Cyt.f RuBisCO Fd FNR A Fe-S CF0 P700 PC 3 H + 3 H + ADP + Pi P700 I

30 OH O 2 - SOD OH NADP GSH H 2 O 2 V.C GSSG NADPH GR GPX APXMDARDHAR GR NADPH GSSG H 2 O MDV.C GSH NADP V.C

31 A B 1 2 Nos-pro LB NPTII V S C M S Q GTC AGT TGC ATG TCG CAA transit peptide HindIII Nos-ter pro KatE tomato rbcs3c gene StuI/SstI Nos-ter RB 93kD Wild tobacco Transformants

32 µmol/mg protein/min µmol/mg chlorophyll/h nmol/mg protein/min cyt chl wild transformant CO2 fix Ru5PK APX 0 hr 48 hr 0 hr 48 hr NADP + O2 e- Photosystems 1/2 O2 PCR/PCO Cycles GSH/ GSSG O2 - /H2O2 H2O DHAR? H2O Ascorbate APX Monodehydro -ascorbate Dehydroascorbate H2O Chloroplast

33

34

35 1 Craterostigma

36

37

38

39 H 2 N : NH 2 C=O NH CH 2 CH 2 CH 2 CH COOH #. #. # % Citrulline Arginine Glutamic acid Glutamine Alanine Serine Aspartic acid (M -1 s -1 ) ( ) X 10 9 ( ) X 10 9 ( ) X 10 8 ( ) X 10 7 Kawasaki et. al., (2000) Plant Cell Physiol., 41, Akashi, et al., (2001) FEBS Lett. 508,

40 b 561 ε-

41 CO 2

42 rbcl mrna RNA/ 3500 DNA DNA Gppp AAAAA DNA10,000 copies/cell Gene Dosage

43 mrna CO2

44

45 CO 2

46

47

48

49 CO 2 O 2 R5P R5P S7P Xu5P SBP SBP Ru5P Xu5P Ru5P RuBP glyoxylate GAP E4P F6P FBP FBP DPGA CO 2 O 2 RuBP RuBisCO PGA PGA GAP GAP glycolate glycine P-glycolate PCO serine glycerate hydroxypyruvate TP DAHP TP

50 UP RuBisCO CO2 UP

51 RuBisCO

p.1127 Chapter 22 Amino Acids, Peptides, and Proteins p.1128 p.1128 Amino acid Peptide Amino acid p.1132 p.1128 p.1129 p.1129 p.1129 p.1130 p.1130 p.1130 p.1130 p.1130 p.1130 p.1130 p.1130 p.1130 p.1130

More information

4 1 Ampère 4 2 Ampere 31

4 1 Ampère 4 2 Ampere 31 4. 2 2 Coulomb 2 2 2 ( ) electricity 2 30 4 1 Ampère 4 2 Ampere 31 NS 2 Fleming 4 3 B I r 4 1 0 1.257 10-2 Gm/A µ 0I B = 2πr 4 1 32 4 4 A A A A 4 4 10 9 1 2 12 13 14 4 1 16 4 1 CH 2 =CH 2 28.0313 28 2

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

(1) PQ (2) () 2 PR = PR P : P = R : R (2) () = P = P R M = XM : = M : M (1) (2) = N = N X M 161 (1) (2) F F = F F F EF = F E

(1) PQ (2) () 2 PR = PR P : P = R : R (2) () = P = P R M = XM : = M : M (1) (2) = N = N X M 161 (1) (2) F F = F F F EF = F E 5 1 1 1.1 2 159 O O PQ RS OR P = PQ P O M MQ O (1) M P (2) P : P R : R () PR P 160 > M : = M : M X (1) N = N M // N X M (2) M 161 (1) E = 8 = 4 = = E = (2) : = 2 : = E = E F 5 F EF F E 5 1 159 (1) PQ (2)

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

カズノコの栄養機能性.ppt

カズノコの栄養機能性.ppt 1.4 1.3 2.4 1.4 1.3 1.2 1.1 1.0 0.9 0.8 1.2 2.0 1.1 1.0 0.9 0.8 1.6 1.2 0.8 1.3 1.2 1.1 1.0 0.9 0.8 R-COOH R CH -O-CO-R 2 1 CH-O-CO-R 2 R CH -O-CO-R 2 3 3. CH -O-CO-R 2 1 CH-O-CO-R2 O CH -O-P-O-X 2 -

More information

untitled

untitled 1 1 2 CADLIVE E-CELL 3 GEM CE/MS MGF WT MGF 4 2 WT E-Cell MASK 5 CE-MS, CE- TOFMS LC-MS 24, 5 9 2 0 6 3 CE-MS CE MS Soga, T. et al. (2002) Anal Chem. 74, 2233-2239 7 CE-MS 859 452, 269, 86 8 4 LC-MS 9

More information

09_organal2

09_organal2 4. (1) (a) I = 1/2 (I = 1/2) I 0 p ( ), n () I = 0 (p + n) I = (1/2, 3/2, 5/2 ) p ( ), n () I = (1, 2, 3 ) (b) (m) (I = 1/2) m = +1/2, 1/2 (I = 1/2) m = +1/2, 1/2 I m = +I, +(I 1), +(I 2) (I 1), I ( )

More information

2 2 MATHEMATICS.PDF 200-2-0 3 2 (p n ), ( ) 7 3 4 6 5 20 6 GL 2 (Z) SL 2 (Z) 27 7 29 8 SL 2 (Z) 35 9 2 40 0 2 46 48 2 2 5 3 2 2 58 4 2 6 5 2 65 6 2 67 7 2 69 2 , a 0 + a + a 2 +... b b 2 b 3 () + b n a

More information

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

More information

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

ブック 1.indb

ブック 1.indb 21 1211 27 11 27 12 16 20 11 27 10 20 28 29 30 12 10 11 12 30 13 30 14 10 30 15 11 16 12 17 13 18 14 19 15 20 16 10 21 11 27 106 21 107 108 109 110 21 111 28 112 28 10 113 29 11 11421 30 12 11521 32 13

More information

CSR報告書2005 (和文)

CSR報告書2005 (和文) A 250 200 150 100 50 0 25,000 20,000 15,000 10,000 5,000 0 1,000 800 600 400 200 0 168 14 14 27 54 60 2000 16,975 1,314 1,207 8,977 5,477 2000 698 112 115 292 178 2000 223 24 28

More information

I II

I II I II I I 8 I I 5 I 5 9 I 6 6 I 7 7 I 8 87 I 9 96 I 7 I 8 I 9 I 7 I 95 I 5 I 6 II 7 6 II 8 II 9 59 II 67 II 76 II II 9 II 8 II 5 8 II 6 58 II 7 6 II 8 8 I.., < b, b, c, k, m. k + m + c + c b + k + m log

More information

untitled

untitled PGF 17 6 1 11 1 12 1 2 21 2 22 2 23 3 1 3 1 3 2 3 3 3 4 3 5 4 6 4 2 4 1 4 2 4 3 4 4 4 5 5 3 5 1 5 2 5 5 5 5 4 5 1 5 2 5 3 6 5 6 1 6 2 6 6 6 24 7 1 7 1 7 2 7 3 7 4 8 2 8 1 8 2 8 3 9 4 9 5 9 6 9 3 9 1 9

More information

QA_H2+3_作2

QA_H2+3_作2 1 Q 1 Q 2 Q 3 Q 4 Q 5 Q 6 Q 7 6 7 8 10 10 11 12 Q 8 Q 9 Q 10 Q 11 Q 12 Q 13 Q 14 Q 15 Q 16 Q 17 Q 18 Q 19 14 15 16 17 18 18 20 22 24 26 28 30 Q 20 Q 21 Q 22 Q 23 Q 24 Q 25 Q 26 Q 27 Q 28 32 33 34 35 36

More information

3/4/8:9 { } { } β β β α β α β β

3/4/8:9 { } { } β β β α β α β β α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3

More information

100 100 6 1 8 10 18 5 12 9 26 2 9 80 2500 7 1400 1 20 7 5 1 3 16 16 16 16 No No.010101 020301 No.020302 021301 TP+3.00 3.06 TP+3.06 3.14 Ho To Ho 1.35m 3.0m To 5.6s 6.8s Ho 2.49m 3.0m

More information

第十四改正日本薬局方第二追補

第十四改正日本薬局方第二追補 461 3 3 3 5 5 6 6 10 18 19 79 81 101 113 127 133 139 145 147 152 153 156 158 165 3 19 20 21 22 22 23 24 25 26 26 27 28 29 29 30 31 dl 32 dl 33 34 34 36 36 37 38 38 38 39 40 42 42 42 43 44 45 46 46 47 48

More information

1: *2 W, L 2 1 (WWL) 4 5 (WWL) W (WWL) L W (WWL) L L 1 2, 1 4, , 1 4 (cf. [4]) 2: 2 3 * , , = , 1

1: *2 W, L 2 1 (WWL) 4 5 (WWL) W (WWL) L W (WWL) L L 1 2, 1 4, , 1 4 (cf. [4]) 2: 2 3 * , , = , 1 I, A 25 8 24 1 1.1 ( 3 ) 3 9 10 3 9 : (1,2,6), (1,3,5), (1,4,4), (2,2,5), (2,3,4), (3,3,3) 10 : (1,3,6), (1,4,5), (2,2,6), (2,3,5), (2,4,4), (3,3,4) 6 3 9 10 3 9 : 6 3 + 3 2 + 1 = 25 25 10 : 6 3 + 3 3

More information

3章 問題・略解

3章 問題・略解 S S W R S O( l) O( ) c Jg g J Jg S R J 7. K.9 JK S W S R S JK S S R J 7. K.9JK 4 (a) -Tice 7.K T ice T N 77 K S R.9 JK 4. JK T T ice N.6JK S W S R S JK S S.6JK R (b) S R JK S.6 JK T T ice N 6 O( c) O(

More information

τ τ

τ τ 1 1 1.1 1.1.1 τ τ 2 1 1.1.2 1.1 1.1 µ ν M φ ν end ξ µ ν end ψ ψ = µ + ν end φ ν = 1 2 (µφ + ν end) ξ = ν (µ + ν end ) + 1 1.1 3 6.18 a b 1.2 a b 1.1.3 1.1.3.1 f R{A f } A f 1 B R{AB f 1 } COOH A OH B 1.3

More information

H1-2_4_P01.qxd

H1-2_4_P01.qxd 77 November 2009 77 November 2009 Cosmo Bio News No.77 1 2 Cosmo Bio News No.77 367 b b Cosmo Bio News No.77 3 Cosmo Bio News No.77 367 e h e b Cosmo Bio News No.77 F B 3 E 6 Cosmo Bio News No.77 367 B

More information

( ) ,

( ) , II 2007 4 0. 0 1 0 2 ( ) 0 3 1 2 3 4, - 5 6 7 1 1 1 1 1) 2) 3) 4) ( ) () H 2.79 10 10 He 2.72 10 9 C 1.01 10 7 N 3.13 10 6 O 2.38 10 7 Ne 3.44 10 6 Mg 1.076 10 6 Si 1 10 6 S 5.15 10 5 Ar 1.01 10 5 Fe 9.00

More information

本組よこ/根間:文11-11_P131-158

本組よこ/根間:文11-11_P131-158 131 132 pp 133 134 a b 135 S pp S 136 a p b p S 137 p S p p H a p b 138 p H p p 139 T T pp pp a b c S a Sp a 140 b c d Sp a b c d e Spp a 141 b c d S a b c d S pp a b 142 c d e S S S S S S S 143 S S S

More information

TOP URL 1

TOP URL   1 TOP URL http://amonphys.web.fc.com/ 1 19 3 19.1................... 3 19.............................. 4 19.3............................... 6 19.4.............................. 8 19.5.............................

More information

1 α X (path) α I = [0, 1] X α(0) = α(1) = p α p (base point) loop α(1) = β(0) X α, β α β : I X (α β)(s) = ( )α β { α(2s) (0 s 1 2 ) β(2s 1) ( 1 2 s 1)

1 α X (path) α I = [0, 1] X α(0) = α(1) = p α p (base point) loop α(1) = β(0) X α, β α β : I X (α β)(s) = ( )α β { α(2s) (0 s 1 2 ) β(2s 1) ( 1 2 s 1) 1 α X (path) α I = [0, 1] X α(0) = α(1) = p α p (base point) loop α(1) = β(0) X α, β α β : I X (α β)(s) = ( )α β { α(2s) (0 s 1 2 ) β(2s 1) ( 1 2 s 1) X α α 1 : I X α 1 (s) = α(1 s) ( )α 1 1.1 X p X Ω(p)

More information

2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO

2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO 1 [1]. Zn + 2 H + Zn 2+,. K Ca Na Mg Al Zn Fe Ni Sn Pb H Cu Hg Ag Pt Au H (H + ),,. [2] ( ) ( ) CO 2, S, SO 2, NH 3 () + () () + () FeS Fe S ( ) + ( ) ( ) + ( ) 2 NH 4 Cl + Ca(OH) 2 Ca O + 2 NH 3,.,,.,,.,.

More information

2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1% 15.2% 16.9% 15.7% 17.1% 18.6% 0.4% 21.4% 15.8% 14.8

2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1% 15.2% 16.9% 15.7% 17.1% 18.6% 0.4% 21.4% 15.8% 14.8 15 7 8,000 15 4 1 0 5 15 4 2 15 10 1 15 4 1 6 11 4,500 3,500 16 26 35 27 34 16 2 19 16 2 24 16 3 15 1 2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1%

More information

(1) θ a = 5(cm) θ c = 4(cm) b = 3(cm) (2) ABC A A BC AD 10cm BC B D C 99 (1) A B 10m O AOB 37 sin 37 = cos 37 = tan 37

(1) θ a = 5(cm) θ c = 4(cm) b = 3(cm) (2) ABC A A BC AD 10cm BC B D C 99 (1) A B 10m O AOB 37 sin 37 = cos 37 = tan 37 4. 98 () θ a = 5(cm) θ c = 4(cm) b = (cm) () D 0cm 0 60 D 99 () 0m O O 7 sin 7 = 0.60 cos 7 = 0.799 tan 7 = 0.754 () xkm km R km 00 () θ cos θ = sin θ = () θ sin θ = 4 tan θ = () 0 < x < 90 tan x = 4 sin

More information

1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1)

1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) 1 9 v..1 c (216/1/7) Minoru Suzuki 1 1 9.1 9.1.1 T µ 1 (7.18) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) E E µ = E f(e ) E µ (9.1) µ (9.2) µ 1 e β(e µ) 1 f(e )

More information

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y)

x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) x, y x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 1 1977 x 3 y xy 3 x 2 y + xy 2 x 3 + y 3 = 15 xy (x y) (x + y) xy (x y) (x y) ( x 2 + xy + y 2) = 15 (x y) ( x 2 y + xy 2 x 2 2xy y 2) = 15 (x y) (x + y) (xy

More information

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COOH COOH COOH COO - CH 2 NH + + CH 2 NH COO - COO - COO

More information

Perl + α. : DNA, mrna,,

Perl + α. : DNA, mrna,, 2009 Perl + α. : DNA, mrna,, DNA .. DNA A C G T DNA 2 A-T, C-G DNA NH 2 NH 2 O - O O N P O - O CH 2 O N N O - O P O CH 2 O N O - O O P O NH 2 O - O - N CH 2 O N O OH OH OH DNA or RNA (U) (A) (G) (C)

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

2012 A, N, Z, Q, R, C

2012 A, N, Z, Q, R, C 2012 A, N, Z, Q, R, C 1 2009 9 2 2011 2 3 2012 9 1 2 2 5 3 11 4 16 5 22 6 25 7 29 8 32 1 1 1.1 3 1 1 1 1 1 1? 3 3 3 3 3 3 3 1 1, 1 1 + 1 1 1+1 2 2 1 2+1 3 2 N 1.2 N (i) 2 a b a 1 b a < b a b b a a b (ii)

More information

n (1.6) i j=1 1 n a ij x j = b i (1.7) (1.7) (1.4) (1.5) (1.4) (1.7) u, v, w ε x, ε y, ε x, γ yz, γ zx, γ xy (1.8) ε x = u x ε y = v y ε z = w z γ yz

n (1.6) i j=1 1 n a ij x j = b i (1.7) (1.7) (1.4) (1.5) (1.4) (1.7) u, v, w ε x, ε y, ε x, γ yz, γ zx, γ xy (1.8) ε x = u x ε y = v y ε z = w z γ yz 1 2 (a 1, a 2, a n ) (b 1, b 2, b n ) A (1.1) A = a 1 b 1 + a 2 b 2 + + a n b n (1.1) n A = a i b i (1.2) i=1 n i 1 n i=1 a i b i n i=1 A = a i b i (1.3) (1.3) (1.3) (1.1) (ummation convention) a 11 x

More information

(Compton Scattering) Beaming 1 exp [i (k x ωt)] k λ k = 2π/λ ω = 2πν k = ω/c k x ωt ( ω ) k α c, k k x ωt η αβ k α x β diag( + ++) x β = (ct, x) O O x

(Compton Scattering) Beaming 1 exp [i (k x ωt)] k λ k = 2π/λ ω = 2πν k = ω/c k x ωt ( ω ) k α c, k k x ωt η αβ k α x β diag( + ++) x β = (ct, x) O O x Compton Scattering Beaming exp [i k x ωt] k λ k π/λ ω πν k ω/c k x ωt ω k α c, k k x ωt η αβ k α x β diag + ++ x β ct, x O O x O O v k α k α β, γ k γ k βk, k γ k + βk k γ k k, k γ k + βk 3 k k 4 k 3 k

More information

untitled

untitled 1 2 NI NI NI 3 4 2008 2008 2008 5 2008 2008 6 II 7 30μm 50μm APHA50 PDP APHA10 PDP 84 TPANI CO2 TPA 90% - - MEK MEK NI TPA CO2-99.9% MEK 99.9MEK 20 tert- tert- NI NI NI 8 MEK tert NI NI 1) NI NIO 2 2 N2O

More information

Step 2 O(3) Sym 0 (R 3 ), : a + := λ 1 λ 2 λ 3 a λ 1 λ 2 λ 3. a +. X a +, O(3).X. O(3).X = O(3)/O(3) X, O(3) X. 1.7 Step 3 O(3) Sym 0 (R 3 ),

Step 2 O(3) Sym 0 (R 3 ), : a + := λ 1 λ 2 λ 3 a λ 1 λ 2 λ 3. a +. X a +, O(3).X. O(3).X = O(3)/O(3) X, O(3) X. 1.7 Step 3 O(3) Sym 0 (R 3 ), 1 1 1.1,,. 1.1 1.2 O(2) R 2 O(2).p, {0} r > 0. O(3) R 3 O(3).p, {0} r > 0.,, O(n) ( SO(n), O(n) ): Sym 0 (R n ) := {X M(n, R) t X = X, tr(x) = 0}. 1.3 O(n) Sym 0 (R n ) : g.x := gxg 1 (g O(n), X Sym 0

More information

(4) P θ P 3 P O O = θ OP = a n P n OP n = a n {a n } a = θ, a n = a n (n ) {a n } θ a n = ( ) n θ P n O = a a + a 3 + ( ) n a n a a + a 3 + ( ) n a n

(4) P θ P 3 P O O = θ OP = a n P n OP n = a n {a n } a = θ, a n = a n (n ) {a n } θ a n = ( ) n θ P n O = a a + a 3 + ( ) n a n a a + a 3 + ( ) n a n 3 () 3,,C = a, C = a, C = b, C = θ(0 < θ < π) cos θ = a + (a) b (a) = 5a b 4a b = 5a 4a cos θ b = a 5 4 cos θ a ( b > 0) C C l = a + a + a 5 4 cos θ = a(3 + 5 4 cos θ) C a l = 3 + 5 4 cos θ < cos θ < 4

More information

TGS(Tri-glycine sulfate, TGS)

TGS(Tri-glycine sulfate, TGS) E s s E D-E FerromagnetisFerroeletris (polar) + T Curie-Weiss sµc/m NaKC 4 H 4 O 6-4H O,RSRS Goettingen( Valasek19 ). -18 4 KH O 4 Bush, Sherrer,1935 KH O 4 Slater(1941) BaTiO 3 Wul, Wainer, Ogawa,1943

More information

36 th IChO : - 3 ( ) , G O O D L U C K final 1

36 th IChO : - 3 ( ) , G O O D L U C K final 1 36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic

More information

瀬田唐橋景観検討について

瀬田唐橋景観検討について 3 3 12,174 /12hr 1,110 /12hr 3,066 /12hr 172.0m 51.75m 23.5+5@25.0+23.5m 3@17.25m 14.0m 15.0m 5 6 2009 12 3 2010 2 25 6/22 8/24 10/18 11/16 1/13 1797 16 15 15 13 6 (S49) 54 7 23-2 24 54 50

More information

ml DNA DNA

ml DNA DNA ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED

More information

Amino Acid Analysys_v2.pptx

Amino Acid Analysys_v2.pptx - α- α- ガスリー法とタンデムマス法の原理 ガスリー法 フェニルアラニンの場合 1 枯草菌のフェニルアラニン依存性菌株を培地で培養 2 乾燥濾紙血をパンチアウトしたディスクを培地上に静置 3 濃度既知のフェニルアラニンを含むディスクを対照として静置 4 濾紙血ディスク周囲の菌成長面積からの比例計算でフェニルアラニン含有濃度を判定 8

More information

( )

( ) 18 10 01 ( ) 1 2018 4 1.1 2018............................... 4 1.2 2018......................... 5 2 2017 7 2.1 2017............................... 7 2.2 2017......................... 8 3 2016 9 3.1 2016...............................

More information

第十五改正日本薬局方第一追補

第十五改正日本薬局方第一追補 316 3 5 7 9 9 9 12 13 14 14 14 23 23 23 24 24 29 29 29 35 37 131 161 173 193 194 198 200 205 3 37 37 37 38 38 38 39 39 40 40 41 42 43 43 45 46 47 48 49 50 51 52 52 53 54 54 54 55 56 58 58 59 60 60 61 61

More information

positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) MeV : thermalization m psec 100

positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) MeV : thermalization m psec 100 positron 1930 Dirac 1933 Anderson m 22Na(hl=2.6years), 58Co(hl=71days), 64Cu(hl=12hour) 68Ge(hl=288days) 0.5 1.5MeV : thermalization 10 100 m psec 100psec nsec E total = 2mc 2 + E e + + E e Ee+ Ee-c mc

More information

Signal Receptor Ion Channel Transmitter Energy transducion and transport Receptor A signal Energy transduction Cross talk Nuclear Cascades B signal As

Signal Receptor Ion Channel Transmitter Energy transducion and transport Receptor A signal Energy transduction Cross talk Nuclear Cascades B signal As ) " " " " 21 Signal Receptor Ion Channel Transmitter Energy transducion and transport Receptor A signal Energy transduction Cross talk Nuclear Cascades B signal Assembly ATP Transport Genetic information

More information

T1 T2 T3 T4 350 mm φ21 100 3.5 15wt% 0wt% 3.0 80 2.5 10wt% 60 2.0 5wt% 5wt% 40 1.5 1.0 10wt% 20 15wt% 0.5 0wt% 0 0.0 100 200 300 400 100 200 300 400 [μm] [μm] [%] [] = 0.9 = 0.5 = 0.1 ( =1.0) FDTD p/λ

More information

2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1

2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 1 45nm 2 2004 2007 2010 90* 65 45 4 10 25 * 100 10001 H16 45 2001-2003 2004-2007 65 45 MIRAI 3 Cu n+ n+ p+ p+ p n nmos pmos ITRS 2004 2007 2010 2013 2016 3.5 k 3.0 2.5 2.0 ITRS2001 ITRS2003 Low-k 1.5 1.0

More information

Donald Carl J. Choi, β ( )

Donald Carl J. Choi, β ( ) :: α β γ 200612296 20 10 17 1 3 2 α 3 2.1................................... 3 2.2................................... 4 2.3....................................... 6 2.4.......................................

More information

A B A E

A B A E 10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258

More information

スライド 1

スライド 1 タンパク質 ( 生化学 1) 平成 29 年 4 月 20 日病態生化学分野 分子酵素化学分野教授 山縣和也 生化学 1のスケジュール 4 月 20 日 講義開始 6 月 1 日 中間試験 9 月 25 日 生化学 1 試験 講義日程 内容は一部変更があります 講義資料 ( 山縣 吉澤分 ): 熊本大学病態生化学 で検索 ID: Biochem2 パスワード :76TgFD3Xc 生化学 1 の合否判定は

More information

1 (Berry,1975) 2-6 p (S πr 2 )p πr 2 p 2πRγ p p = 2γ R (2.5).1-1 : : : : ( ).2 α, β α, β () X S = X X α X β (.1) 1 2

1 (Berry,1975) 2-6 p (S πr 2 )p πr 2 p 2πRγ p p = 2γ R (2.5).1-1 : : : : ( ).2 α, β α, β () X S = X X α X β (.1) 1 2 2005 9/8-11 2 2.2 ( 2-5) γ ( ) γ cos θ 2πr πρhr 2 g h = 2γ cos θ ρgr (2.1) γ = ρgrh (2.2) 2 cos θ θ cos θ = 1 (2.2) γ = 1 ρgrh (2.) 2 2. p p ρgh p ( ) p p = p ρgh (2.) h p p = 2γ r 1 1 (Berry,1975) 2-6

More information

untitled

untitled i ii T U 1 U T... 3 2... 5 3... 5 4... 6 5... 6 6... 6 7 ()... 6 8 SS... 7 9 SS... 7 1-1... 15 1-2 /... 16 1-3... 17 1-4 /... 19 1-5... 19 1-6... 21 1-7 SS (/... 21 1-8... 22 1-9... 22 1-10... 23 1-11

More information

K E N Z U 2012 7 16 HP M. 1 1 4 1.1 3.......................... 4 1.2................................... 4 1.2.1..................................... 4 1.2.2.................................... 5................................

More information

prime number theorem

prime number theorem For Tutor MeBio ζ Eite by kamei MeBio 7.8.3 : Bernoulli Bernoulli 4 Bernoulli....................................................................................... 4 Bernoulli............................................................................

More information

第十四改正日本薬局方第一追補

第十四改正日本薬局方第一追補 395 3 5 7 7 7 7 8 16 17 19 159 161 181 207 231 231 233 235 240 253 259 263 3 19 19 21 21 22 22 23 24 25 26 26 26 26 26 26 27 27 28 44 45 45 46 48 49 49 49 50 51 52 53 54 54 55 55 56 56 57 57 58 59 60 61

More information

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m 1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

More information

untitled

untitled C08036 C08037 C08038 C08039 C08040 1. 1 2. 1 2.1 1 2.2 1 3. 1 3.1 2 4. 2 5. 3 5.1 3 5.2 3 6. 4 7. 5 8. 6 9. 7 10. 7 11. 8 C08036 8 C08037 9 C08038 10 C08039 11 C08040 12 8 2-1 2-2 T.P. 1 1 3-1 34 9 28

More information

熊本県数学問題正解

熊本県数学問題正解 00 y O x Typed by L A TEX ε ( ) (00 ) 5 4 4 ( ) http://www.ocn.ne.jp/ oboetene/plan/. ( ) (009 ) ( ).. http://www.ocn.ne.jp/ oboetene/plan/eng.html 8 i i..................................... ( )0... (

More information

高オレイン酸ダイズ( GmFad2-1, Glycine max (L.) Merr.)(260-05, OECD UI :DD- Ø26ØØ5-3) 申請書等の概要

高オレイン酸ダイズ( GmFad2-1, Glycine max (L.) Merr.)(260-05, OECD UI :DD- Ø26ØØ5-3) 申請書等の概要 GmFad2-1, Glycine max (L.) Merr. (260-05, OECD UI : DD- Ø26ØØ5-3)...1 1... 2 1... 2 ( )... 2... 2... 2... 2 ( )... 2... 2... 2 ( )... 3... 3... 3... 3... 4... 4... 5... 5 2... 5 ( )... 5... 5... 6 ( )...

More information

【資料4】「健康な食事」資料集

【資料4】「健康な食事」資料集 資料 4 日本人の長寿を支える 健康な食事 のあり方に関する検討会 H25.6.24 24 21 60 65 70 75 80 85 90 70.42 73.62 79.55 86.30 34 22 22 (22 ) 1 65 38.8 24.2 (2012) 12.1 2 10 2522 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 15.1 6.1 3.5

More information

1 (Contents) (1) Beginning of the Universe, Dark Energy and Dark Matter Noboru NAKANISHI 2 2. Problem of Heat Exchanger (1) Kenji

1 (Contents) (1) Beginning of the Universe, Dark Energy and Dark Matter Noboru NAKANISHI 2 2. Problem of Heat Exchanger (1) Kenji 8 4 2018 6 2018 6 7 1 (Contents) 1. 2 2. (1) 22 3. 31 1. Beginning of the Universe, Dark Energy and Dark Matter Noboru NAKANISHI 2 2. Problem of Heat Exchanger (1) Kenji SETO 22 3. Editorial Comments Tadashi

More information

C 3 C-1 Ru 2 x Fe x CrSi A A, A, A, A, A Ru 2 x Fe x CrSi 1) 0.3 x 1.8 2) Ru 2 x Fe x CrSi/Pb BTK P Z 3 x = 1.7 Pb BTK P = ) S.Mizutani, S.Ishid

C 3 C-1 Ru 2 x Fe x CrSi A A, A, A, A, A Ru 2 x Fe x CrSi 1) 0.3 x 1.8 2) Ru 2 x Fe x CrSi/Pb BTK P Z 3 x = 1.7 Pb BTK P = ) S.Mizutani, S.Ishid C 3 C-1 Ru 2 x Fe x CrSi A A, A, A, A, A Ru 2 x Fe x CrSi 1).3 x 1.8 2) Ru 2 x Fe x CrSi/Pb BTK P Z 3 x = 1.7 Pb BTK P =.52 1) S.Mizutani, S.Ishida, S.Fujii and S.Asano, Mater. Tran. 47(26)25. 2) M.Hiroi,

More information

( ) FAS87 FAS FAS87 v = 1 i 1 + i

( ) FAS87 FAS FAS87 v = 1 i 1 + i ( ) ( 7 6 ) ( ) 1 6 1 18 FAS87 FAS87 7 1 FAS87 v = 1 i 1 + i 10 14 6 6-1 - 7 73 2 N (m) N L m a N (m) L m a N m a (m) N 73 9 99 18 4-2 - 4 143 2 145 3 37 4 37 4 40 6 40 6 41 10 41 10 13 10 14 4 24 3 145

More information

From Evans Application Notes

From Evans Application Notes 3 From Evans Application Notes http://www.eaglabs.com From Evans Application Notes http://www.eaglabs.com XPS AES ISS SSIMS ATR-IR 1-10keV µ 1 V() r = kx 2 = 2π µν x mm 1 2 µ= m + m 1 2 1 k ν = OSC 2

More information

A

A A 2563 15 4 21 1 3 1.1................................................ 3 1.2............................................. 3 2 3 2.1......................................... 3 2.2............................................

More information

untitled

untitled /, S=1/2 S=0 S=1/2 - S// m H m H = S G e + + G Z (t) 1 0 t G Z (t) 1 0 t G Z (t) 1 0 t SR G Z (t) = 1/3 + (2/3)(1-2 t 2 )exp(- 2 t 2 /2) G Z (t) 1-1/3 1/3 0 3/ 3/ t G Z (t)

More information

Glycobiology Glycobiology SPECIAL ISSUE Glycobiology CONTENTS 7 8 8 9 11 11 13 13 14 15 16 16 21 22 22 22 22 25 25 25 26 27 27 27 28 28 30 32 32 32 33 33 33 34 36 38 42 43 Glycoprotein 46 48 48 50 51

More information

H1-P15

H1-P15 72 January 2009 72 January 2009 72 January 2009 2008 GFP GFP 1992 Prasher cdna GFP Aequorea victoria GFP cdna in vivo EGFP GFP FACS GFP GFP GFP GFP 1. Prasher, D.C., et al. 1992. Primary structure of the

More information

会報35号表紙.pdf

会報35号表紙.pdf 35 No. (2017 1 ) RNA 2017 2017 TV 365 365 chunky 26 RNA 2017 Congratulations26 30-1 - RNA 2017-2 - - 3 - - 4 - - 5 - - 6 - 2016 8 31 9 2 RNA 2016 1 RNA RNA RNA RNA RNA 1-7 - RNA RNA 3 3 7 31 RNA ncrna

More information